2019 Technical Presentation: ASTA Webinar on Allergens in Spices: Risk Assessments and Regulatory Risks
This webinar includes an overview of the history of past incidents involving allergens in spices and a deep dive into conducting quantitative risk assessments for allergens in spices. The webinar addresses safety risks due to the presence of allergens in spices for food-allergic consumers, as well as business and regulatory implications. Additionally, the webinar covers when products need to be reported or recalled, how to work with government agencies if an allergen is detected, an update on FDA thresholds, as well as other FDA and USDA policy and regulatory updates related to allergens. Martin J. Hahn, Partner, Hogan Lovells US LLP, and Dr. Steve L. Taylor, Emeritus Professor and Founding Director, Food Allergy Research and Resource Program (FAARP), provided this presentation.
Membership Required
A valid ASTA membership is required to access this page. Please use the form below to log in with your ASTA member account.
Log in
Not a member yet? Click here to learn about joining ASTA today.
Related Resources
2021 Regulatory Workshop: Food Allergens and Allergen Management
This presentation was provided at the 2021 Regulatory Workshop. The presenter, Joe Baumert, presented on what the future holds for Food Allergens and Allergen Management, including details on the FASTER Act and PAL statements.
A Closer Look at FDA’s Guidance on Food Allergens Webinar
Presented on Friday, July 26, 2024. Undeclared allergens continue to be the leading cause of food recalls, and allergen control programs are commonly cited in 483s and Warning Letters. In the fall of 2023, the FDA released Chapter 11 of FDA’s Hazard Analysis and Risk-Based Preventive Controls for Human Food draft guidance, which addresses the FDA’s current thinking on how to develop and implement robust allergen preventive controls and cGMP programs. Additionally, in the fall of 2022, the FDA issued two guidance documents about food allergen labeling, including notable recommendations on allergen advisory labeling issues. In this webinar, Maile Gradison and Anneke Altieri will offer a deep dive into these guidance documents and share insight into the FDA’s expectations for allergen management programs, including label content and controls, supplier verification activities, advisory allergen labeling, and cGMPs.
